The Canadian provinces of Newfoundland and Quebec and Labrador said Wednesday they might not allow the sale of cannabis vapes, just weeks earlier than the beginning of marijuana derivatives sales, as concerns linger about a possible relation between the vaping products and severe lung issues
“We won’t be selling vaping products on Jan. 1,” Fabrice Giguère, Société québécoise du cannabis spokesperson, which sales marijuana in the area, mentioned by email, adding the province had not officially declared its stance.
All of Quebec’s legal hashish stores are run by the provincial government, while Newfoundland and Labrador’s shops are private.
Earlier Wednesday, Newfoundland, and Labrador, which like Canada’s easternmost province, was the first to start sales of legal marijuana in 2018, stated it could not allow cannabis vape products, however, it would review the rule in light of any new medical evidence.
There have been 11 cases of extreme lung illnesses in Canada tied to vaping, based on data from the Canadian government, which has mentioned it is probing the cause.
The U.S. Centers for Disease Control and Prevention on November 21 identified vitamin E acetate, an additive that’s often mixed with marijuana oil in the illegal cannabis market, as a “chemical of concern.”
“The rule intends to guard the health of the people in this region until there’s more proof about the relation between cannabis vaping products and extreme lung disease,” the Newfoundland and Labrador government mentioned in an announcement.